Arnaud Jannin

Lille, 59037, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Preparation for parathyroid surgery.

Preparation for parathyroid surgery.

Journal: Journal of visceral surgery

Published: August 18, 2026

NKX6.1 mRNA copy number is an actionable biomarker associated with islet function and clinical outcomes after islet transplantation.

NKX6.1 mRNA copy number is an actionable biomarker associated with islet function and clinical outcomes after islet transplantation.

Journal: Science translational medicine

Published: March 25, 2026

Bone phenotype in familial partial lipodystrophy type 2: Insulin resistance and sclerostin.

Bone phenotype in familial partial lipodystrophy type 2: Insulin resistance and sclerostin.

Journal: Diabetes & metabolism

Published: February 13, 2026

Rebuilding Beta-Cell Function: Advances In Replacement, Preservation And Regeneration.

Rebuilding Beta-Cell Function: Advances In Replacement, Preservation And Regeneration.

Journal: Annales d'endocrinologie

Published: January 23, 2026

Management of Hemodialyzed Patients Treated with Radioactive Iodine for Thyroid Cancer: How Could We Improve It? Tracks from the Lille Experience.

Management of Hemodialyzed Patients Treated with Radioactive Iodine for Thyroid Cancer: How Could We Improve It? Tracks from the Lille Experience.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 28, 2025

[177Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial.

[177Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial.

Journal: The Lancet. Oncology

Published: November 04, 2025

French expert consensus statement on diagnosis and management of primary hyperparathyroidism.

French expert consensus statement on diagnosis and management of primary hyperparathyroidism.

Journal: Annales d'endocrinologie

Published: September 01, 2025

ENDOCAN-TUTHYREF guidelines. Locoregional therapies for locally advanced and/or metastatic thyroid cancer.

ENDOCAN-TUTHYREF guidelines. Locoregional therapies for locally advanced and/or metastatic thyroid cancer.

Journal: Annales d'endocrinologie

Published: April 22, 2025

ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancer.

ENDOCAN-TUTHYREF network consensus recommendations. Refractory medullary thyroid cancer.

Journal: Annales d'endocrinologie

Published: April 07, 2025

ENDOCAN TUTHYREF network consensus recommendations: Anaplastic thyroid cancer.

ENDOCAN TUTHYREF network consensus recommendations: Anaplastic thyroid cancer.

Journal: Annales d'endocrinologie

Published: April 06, 2025

ENDOCAN TUTHYREF network consensus recommendations: Refractory follicular-derived thyroid cancer.

ENDOCAN TUTHYREF network consensus recommendations: Refractory follicular-derived thyroid cancer.

Journal: Annales d'endocrinologie

Published: April 06, 2025

Performance of afternoon (16:00 h) serum cortisol for the diagnosis of Cushing's syndrome.

Performance of afternoon (16:00 h) serum cortisol for the diagnosis of Cushing's syndrome.

Journal: Clinical chemistry and laboratory medicine

Published: February 05, 2025

Showing 1-12 of 68

Last Updated: 09/26/2026